Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide

医学 乳腺癌 乳腺闪烁照相术 剂量学 药代动力学 核医学 分子成像 癌症 伽玛照相机 内科学 乳腺摄影术 体内 生物 生物技术
作者
Javad Biabani Ardakani,Seyed Mohammad Abedi,Alireza Mardanshahi,Leyla Shojaee,Ehsan Zaboli,Alireza Khorramimoghaddam,Anahita Nosrati,Hamideh Sabahno,Elahm Sadat Banimostafavi,Seyed Jalal Hosseinimehr
出处
期刊:Clinical Breast Cancer [Elsevier BV]
卷期号:23 (2): 219-230 被引量:6
标识
DOI:10.1016/j.clbc.2022.12.002
摘要

The accurate determination of human epidermal growth factor receptor 2 (HER2) status can predict response to treatment with HER2-targeted therapy for HER2-positive breast cancer patients. [99mTc]Tc-HYNIC-(Ser)3-LTVPWY ([99mTc]Tc-HYNIC-LY) is a small synthetic peptide molecule targeting of the HER2 receptor. This clinical study evaluated the pharmacokinetic, dosimetry, and efficacy of [99mTc]Tc-HYNIC-LY for determining the HER2 status in primary breast cancer patients.In total, 24 women with suspected primary breast cancer received an intravenous injection of approximately 20 µg (∼740 MBq) of [99mTc]Tc-HYNIC-LY. In the first 3 patients, blood levels of radioactivity were analyzed for pharmacokinetic evaluation and planar gamma camera imaging was conducted at 30 min and 1, 2, 4, and 24 hour after injection for dosimetry assessment. In the last 21 patients, planar imaging was performed at the baseline, as well as 1, 2, 3, and 4 hour, followed by single-photon emission computed tomography (SPECT) imaging after 4 hour to evaluate the tumor-targeting potential in primary lesions.Injection of [99mTc]Tc-HYNIC-LY was safe and well tolerated. Fast blood clearance provided high-contrast HER2 imaging within 1 to 4 hour. The highest absorbed radiation dose was found for kidneys (6.78E-03 ± 2.62E-04 mSv/MBq), followed by the heart (3.73E-03 ± 1.98E-04 mSv/MBq). The [99mTc]Tc-HYNIC-LY peptide was able to detect HER2 status in primary tumors at an acceptable level.The findings of this study indicated that [99mTc]Tc-HYNIC-LY SPECT is safe and feasible for the identification of HER2-positive lesions in primary breast cancer patients, and may provide an accurate and non-invasive modality for guiding HER2 targeted therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
二重音发布了新的文献求助10
1秒前
2秒前
4秒前
皮肤科王东明完成签到,获得积分10
4秒前
黑大帅发布了新的文献求助10
5秒前
6秒前
所所应助皮肤科王东明采纳,获得10
6秒前
ww完成签到,获得积分10
7秒前
闾丘剑封发布了新的文献求助10
9秒前
智慧者发布了新的文献求助10
9秒前
银杏完成签到 ,获得积分10
9秒前
10秒前
基尔霍夫完成签到,获得积分10
11秒前
12秒前
sss2021发布了新的文献求助20
12秒前
13秒前
lzx发布了新的文献求助10
17秒前
学不会发布了新的文献求助10
17秒前
枫叶问海棠完成签到,获得积分20
21秒前
量子星尘发布了新的文献求助10
22秒前
22秒前
为妳铭记完成签到 ,获得积分10
22秒前
22秒前
22秒前
葉鳳怡完成签到 ,获得积分10
24秒前
学不会完成签到,获得积分10
24秒前
27秒前
西风白马完成签到,获得积分10
27秒前
27秒前
31秒前
32秒前
33秒前
小蘑菇应助lzx采纳,获得10
34秒前
酷波er应助科研通管家采纳,获得10
35秒前
大模型应助科研通管家采纳,获得10
35秒前
斯文败类应助科研通管家采纳,获得10
35秒前
星辰大海应助科研通管家采纳,获得10
35秒前
CodeCraft应助科研通管家采纳,获得10
35秒前
Owen应助科研通管家采纳,获得10
35秒前
彭于晏应助科研通管家采纳,获得10
35秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989444
求助须知:如何正确求助?哪些是违规求助? 3531531
关于积分的说明 11254250
捐赠科研通 3270191
什么是DOI,文献DOI怎么找? 1804901
邀请新用户注册赠送积分活动 882105
科研通“疑难数据库(出版商)”最低求助积分说明 809174